Thursday, April 18, 2024
Home Uncategorized

Uncategorized

    Featured posts

    ABVC BioPharma (ABVC) Approved for ABV-1505 Phase II Part II in Taiwan Sites

    Uncategorized Editor / Curator -
    Gentleman, Start Your Engines? ABVC BioPharma Receives Taiwan Regulatory Approval for ABV-1505 ADHD Phase II Part 2 Clinical Study

    Lantern Pharma (LTRN) $21.25 and Provention Bio (PRVB) $13.51 Added to Biotech Six Pack.

    Uncategorized Editor / Curator -
    The 2021 Biotech Six Pack: Stocks We Expect to Double! These are ideas #3 and #4 for the 'Biotech...
    video

    CoronaVirus Story of the Day. “How Lucky Can One Guy Be.”

    Superbug News - CoronaVirus Watch List Editor / Curator -
    LIVE QUOTE How lucky, or how clever!

    The Hottest Wearable Tech and Smart Gadgets of 2016

    Uncategorized Editor / Curator -
    All right. Well, take care yourself. I guess that's what you're best, presence old master? A tremor in the Force. The last time felt...

    Latest article

    Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...

    All News Editor / Curator -
    Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...

    Major Mpox Outbreak in the Democratic Republic of Congo.

    Mpox Editor / Curator -
    As Reported in NPR's Gates and Soda Major Mpox Outbreak in the Democratic Republic of Congo is a...

    Mpox Infections Rise to Almost Double Last Year’s Numbers.

    All News Editor / Curator -
    The number of mpox cases in 2024 is already nearly double the number of cases that were detected in all of...
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: [email protected]
    © Managed by Revelers.IO Media Group Inc.